Resumo

REYES, Luis et al. Clinical variability of vecuronium. Experience at an Institution in Colombia. Rev. colomb. anestesiol. [online]. 2012, vol.40, n.4, pp.251-255. ISSN 0120-3347.  https://doi.org/10.1016/j.rca.2012.06.003.

Objective: To establish the variability of vecuronium (lag-time, latency duration, clinical duration and complete recovery), original molecule, in a group of patients that received the agent prior to surgery under general anesthesia with endotracheal intubation. Materials and methods: Observational, prospective study including 20 adult patients - ASA I or II classification - selected on the basis of suitability, who received general anesthesia and vencuronium as neuromuscular relaxant. Remifentanyl and propofol were the induction agents. The neuromuscular activity was quantified using a TOF-WATCH SX® stimulator, establishing lag-time, duration of latency, clinical duration and complete recovery. The data were analyzed using STATA 10. Results: The data on lag-time to complete recovery, are given as medians: lag-time: 32.5 seconds; latency time: 240 seconds; clinical length 25: 43.5 min; clinical length 50: 57.5 min; clinical length 75: 58.5 min; clinical length 100: 55 min. Complete recovery: 87 min. Need for reversion: 55%. Adverse effects: none. Conclusions: The results obtained suggest a broad variability between the time of administration of vecuronium, its clinical effect and duration of action, all of which were above the levels recorded in the literature. This suggests that the agent is long-acting and highly unpredictable. We recommend neuromuscular function monitoring as an indispensable routine and preferably quantitative.

Palavras-chave : Neuromuscular blocking agents; Anesthesiology; Intratracheal intubation; Colombia.

        · resumo em Espanhol     · texto em Espanhol | Inglês     · Inglês ( pdf ) | Espanhol ( pdf )